The tumor cells show a B-cell phenotype with expression of the transcription factors BOB1 and OCT2 and often a non-GCB phenotype with lack of CD10 expression but expression of MUM1, BCL6, and MEF2B (Fig. 1J–K). This evidence concerns the gene IRF4 and neoplasm.